IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) Price CAGR:7.15%(TTM)

Compare

The price cagr for IDEXX Laboratories, Inc. (IDXX) is +7.15% over the latest trailing 12-month period. The comparable SPY value is +20.75%. Year-to-date price return is -15.89%. Price CAGR uses adjusted close price history and excludes dividends.

The price CAGR for IDEXX Laboratories, Inc. (IDXX) stock is 7.15% over the past 12 months. The 3 year CAGR is 7.71% and the 5 year CAGR is -0.59%. The price CAGR (Compound Annual Growth Rate) shows how IDEXX Laboratories, Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.

IDXX Price CAGR Chart

IDEXX Laboratories, Inc. (IDXX)

IDXX Price CAGR History

YearStart PriceEnd PriceChange% ChangeCAGR
2025491.49527.78+36.29+7.38%+7.38%
2024490.72491.49+0.77+0.16%+0.16%
2023332.03490.72+158.69+47.79%+47.79%
2022606.63332.03-274.60-45.27%-45.27%
2021314.67606.63+291.96+92.78%+92.78%
2020272.88314.67+41.79+15.31%+15.31%
2019225.38272.88+47.50+21.08%+21.08%
2018164.38225.38+61.00+37.11%+37.11%
201787.66164.38+76.72+87.52%+87.52%
201667.2687.66+20.40+30.33%+30.33%
201565.6767.26+1.59+2.41%+2.41%
201445.2465.67+20.43+45.15%+45.15%
201343.9945.24+1.25+2.84%+2.84%
201236.5543.99+7.45+20.37%+20.37%
201132.3536.55+4.20+12.98%+12.98%
201022.2932.35+10.07+45.16%+45.16%
200925.6522.29-3.36-13.12%-13.12%
200822.1225.65+3.53+15.96%+15.96%
200719.3222.12+2.80+14.51%+14.51%
200614.0019.32+5.32+37.98%+37.98%
200516.1614.00-2.16-13.35%-13.35%
20049.0016.16+7.16+79.53%+79.53%
20037.019.00+1.99+28.30%+28.30%
20027.407.01-0.38-5.17%-5.17%
20016.527.40+0.88+13.53%+13.53%
20006.506.52+0.02+0.24%+0.24%
19995.166.50+1.34+26.06%+26.06%
19983.415.16+1.75+51.38%+51.38%
19975.593.41-2.18-39.07%-39.07%

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky